Literature DB >> 10544453

[Analysis of some viral infections, transmitted by parenteral and sexual routes, in the Republic of Azerbaijan].

S A Galetskiĭ, N B Seniuta, A V Syrtsev, O M Abdullaev, D A Aliev, A A Kerimov, M Yamashita, M Hayami, T Kato, M Mizokami.   

Abstract

Representatives of various population groups in Azerbaijan were tested for infection with human T-lymphotropic (HTLV-I and HTLV-II) and hepatotropic viruses (HCV and HBV). A total of 835 sera were studied by screening and specific tests for virus-specific antibodies and/or antigens. Thirty-five DNA specimens from peripheral blood lymphocytes were analyzed in the PCR for HTLV-I-specific sequences. No HTLV-I or HIV were detected, but two cases with integration of the HTLV-I LTR gene into cellular DNA genome were detected. A high rate of infection with hepatitis B and C was revealed. The level of anti-HCV was 8.7%, HBsAg 4.1%, and antiHBs 23.4%. Six cases with double HBV-HCV infection were detected. High values of ALT among HBV/HCV-seronegative subjects prompts their testing for other types of hepatitis viruses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544453

Source DB:  PubMed          Journal:  Vopr Virusol        ISSN: 0507-4088


  3 in total

1.  Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan.

Authors:  Zhannat Z Nurgalieva; F Blaine Hollinger; David Y Graham; S Zhangabylova; Abai Zhangabylov
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

Review 2.  Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.

Authors:  Freke R Zuure; Anouk T Urbanus; Miranda W Langendam; Charles W Helsper; Charlotte H S B van den Berg; Udi Davidovich; Maria Prins
Journal:  BMC Public Health       Date:  2014-01-22       Impact factor: 3.295

3.  Prevalence of Hepatitis C Virus Infection in General Population of Mashhad, Northeastern Iran.

Authors:  Sanaz Ahmadi Ghezeldasht; Mohammad Reza Hedayati-Moghaddam; Khosro Shamsian; Farhad Fathimoghadam; Hamid Reza Bidkhori; Seyed Abdolrahim Rezaee
Journal:  Iran J Public Health       Date:  2017-03       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.